Beijing Saisun Pharmaceutical Co., Ltd. will hold an online performance briefing on April 21, 2026, from 15:00 to 16:30. The meeting aims to address investor inquiries regarding the company's 2025 annual report and operational performance. Investors can submit questions in advance via a designated website or WeChat. Key participants include the Chairman and General Manager, CFO, and independent directors.
Summary generated by AI · Always verify with source document
Securities Code: 300485
Securities Abbreviation: Saisun Pharmaceutical
Announcement Number: 2026-014
Beijing Saisun Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.